ID-14009

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameID-14009
Drug Alias NameID-14009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitorsVoltage-gated calcium channel blockersAngiotensin II Receptor Type 1 antagonists +[5] 
TargetsHMG-CoA reductaseVoltage-gated calcium channelAngiotensin II Receptor Type 1 +[4] 
Therapy Area/IndicationsDyslipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Rosuvastatin CalciumAmlodipineValsartan
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIldong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIldong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsDyslipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A